Episode #38 - NINDS and Its Role in Epilepsy Research featuring Vicky Whittemore


NINDS… what do the letters mean?  And more importantly, what does NINDS have to do with epilepsy research? We go past the acronym to shed light on what this important government agency is doing to move the epilepsy research agenda forward.

On this episode of Seizing Life, Dr. Vicky Whittemore, Program Director for Epilepsy and Epileptogenesis at NINDS and CURE Scientific Advisory Council member, explains how NINDS sets prioriites, funds research, and collaborates with non-profits to move science forward in pursuit of new treatments for epilepsy.

Download Audio

Want to download this episode? Fill out the form below and enjoy the podcast any time you’d like!

    Back to Episode Download PDF

    NINDS and Its Role in Epilepsy Research - Transcript

    Related Episodes

    featured episode
    Infantile SpasmsResearch
    November 29, 2023

    #130 Infantile Spasms: The Facts, The Research, and The Hope for the Future

    Guest: Dr. Chris Dulla

    This week on Seizing Life® epilepsy researcher Dr. Chris Dulla provides information about infantile spasms, from detection and diagnosis to current research and future improvements in treatment.

    featured episode
    October 18, 2023

    #127 Searching for Answers, Providing Support, and Understanding Grief After the Death of a Child

    Guest: Dr. Richard Goldstein

    This week on Seizing Life® Dr. Richard Goldstein, Associate Professor of Pediatrics at Harvard Medical School, discusses his research into both Sudden Unexpected Death in Pediatrics (SUDP) and the grieving process of bereaved parents.

    featured episode
    May 31, 2023

    #117 Epilepsy Researcher Compounds Lab Work with Fundraising

    Guest: Dr. Patrice Jackson-Ayotunde

    This week on Seizing Life® Dr. Patrice Jackson-Ayotunde discusses her 20+ years of epilepsy drug research and her decade-long epilepsy fundraising efforts.


      Join our email list for the
      latest epilepsy research news,
      discoveries, and more.